Article ; Online: Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial.
International journal of chronic obstructive pulmonary disease
2024 Volume 19, Page(s) 205–216
Abstract: Purpose: Real-life effectiveness data on once-daily single-inhaler triple therapy (odSITT) with the inhaled corticosteroid fluticasone furoate (FF), the long-acting muscarinic antagonist umeclidinium (UMEC), and the long-acting β: Patients and methods! ...
Abstract | Purpose: Real-life effectiveness data on once-daily single-inhaler triple therapy (odSITT) with the inhaled corticosteroid fluticasone furoate (FF), the long-acting muscarinic antagonist umeclidinium (UMEC), and the long-acting β Patients and methods: ELLITHE was a single-country (Germany), multicenter, open-label, non-interventional effectiveness study between 2020 and 2022, evaluating the effect of treatment initiation with FF/UMEC/VI 100/62.5/25 µg once-daily via the ELLIPTA inhaler on improvements in clinical outcomes versus baseline in COPD patients. The primary endpoint was the change in the total COPD Assessment Test (CAT) score between baseline and month 12. Key secondary endpoints included change in CAT score over time, occurrence of exacerbations until month 12, changes in forced expiratory volume in one second (FEV Results: Nine hundred and six patients were included (age 66.6 years, 55.6% male, mean FEV Conclusion: In usual care, treatment with odSITT resulted in significant and clinically relevant improvements of CAT score and FEV |
---|---|
MeSH term(s) | Humans ; Male ; Aged ; Female ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Fluticasone ; Nebulizers and Vaporizers ; Androstadienes ; Benzyl Alcohols ; Chlorobenzenes ; Quinuclidines |
Chemical Substances | fluticasone furoate (JS86977WNV) ; GSK573719 ; vilanterol (028LZY775B) ; Fluticasone (CUT2W21N7U) ; Androstadienes ; Benzyl Alcohols ; Chlorobenzenes ; Quinuclidines |
Language | English |
Publishing date | 2024-01-17 |
Publishing country | New Zealand |
Document type | Multicenter Study ; Journal Article |
ZDB-ID | 2212419-6 |
ISSN | 1178-2005 ; 1176-9106 |
ISSN (online) | 1178-2005 |
ISSN | 1176-9106 |
DOI | 10.2147/COPD.S427770 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.